期刊文献+

伐昔洛韦缓释片体外释放速率与人体内吸收速率的相关性

Correlation between dissolution rate in vitro and absorption rate in vivo of valaciclovir sustained release tablets
下载PDF
导出
摘要 目的:研究伐昔洛韦缓释片体外释放速率与人体内吸收速率的相关性。方法:以水为释放介质,测定伐昔洛韦缓释片的体外释放速率;采用Wagner-Nelson法计算单剂量口服缓释片后体内吸收分数,考察吸收相体内吸收与体外释放的相关性。结果:伐昔洛韦缓释片体内吸收分数(f_a)与体外释放速率(f_r)的关系为:f_a=2.11f_r -20.12,r=0.994 0(n=5)。结论:伐昔洛韦缓释片人体内外相关性良好(P<0.001)。 AIM: To explore the in vivo-in vitro correlation of valaciclovir sustained release tablets (VSRT) . METHODS: In vitro release rate of VSRT was studied by the Chp basket method using the following conditions: in 900 ml of water at (37.5 ± 0.5) ℃ at a rotation speed of 100 rpm. In vivo bioavailability was tested in twenty healthy male volunteers and the fractions absorbed were calculated by Wagner-nelson method. RESULTS: The relationship between the release fraction (fr) and the absorption fraction (fa) was: fa =2.11 fr - 20.12, r = 0.994 0 (n = 5) . CONCLUSION: There is a good correlationship of VSRT between dissolution rate in vitro and absorption rate in vivo.
出处 《中国新药与临床杂志》 CAS CSCD 北大核心 2007年第10期759-761,共3页 Chinese Journal of New Drugs and Clinical Remedies
关键词 伐昔洛韦 片剂 迟效制剂 体内外相关 Wagner-Nelson法 valaciclovir tablets delayed-action preparation in vivo-in vitro correlation Wagner-Nelson method
  • 相关文献

参考文献6

二级参考文献31

  • 1杨明世,游本刚,杨明华,寸冬梅,陶安进,崔福德.脱卷积法进行自制尼群地平缓释制剂体内外相关性研究[J].药学学报,2004,39(9):738-741. 被引量:17
  • 2程现頲,刘振平,杜秀琴.阿昔洛韦治疗急性单纯疱疹病毒性脑炎[J].新药与临床,1995,14(4):247-248. 被引量:2
  • 3肖正中,吴海雁.多烯康与阿昔洛韦比较治疗带状疱疹[J].新药与临床,1997,16(1):24-25. 被引量:6
  • 4蒋学华,陈小瑞,程强,胡继承,孙健.盐酸伐昔洛韦片的药动学与生物利用度[J].中国药学杂志,1997,32(2):100-103. 被引量:20
  • 5Balan G, Timmins P, Greene DS, et al. In vitro-in vivo correlation models for metformin after administration of modified-release oral dosage forms to healthy human volunteers [ J]. J Pharm Sci, 2001,90(8): 1176 - 1185.
  • 6Krol GJ, Lettieri JT, Yeh SC, et al. Disposition and pharmacokinetics of 14C-nitrendipine in healthy volunteers [J]. J Cardiovasc Pharmacol, 1987,9(Suppl 4) :S122-S128.
  • 7Langenbucher F, Mysicka J. In vitro and in vivo deconvolution assessment of drug release kinetics from oxprenolol oros preparations [J]. Br J Clin Pharmacol,1985,19:151S - 162S.
  • 8Wagner JG. Do you need a pharmacokinetic method, and if so, which one? [J] J Pharmacokin Biopharm, 1975,3(6) :457-478.
  • 9Vaughan DP, Nennis M. Mathematical basis of pointarea deconvolution method for determining in vivo input functions [J]. J Pharm Sci, 1978,67(5) :663 -665.
  • 10Ichiro S,Yukari O.New drugsreports of new drugs recently approved by the FDA:Valacyclovir.B ioorg Med Chem,1996,4(1):1

共引文献52

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部